OpenRx Open Medications Explorer
© 2026 OpenRx · public-domain U.S. government data
On this page

Egrifta SV

tesamorelin

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Egrifta SV
Proper name
tesamorelin
Licence type
351(a)
BLA number
022505
Applicant
Theratechnologies Inc.
Center
CDER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
2MG For Injection Subcutaneous Single-Dose Vial Rx November 29, 2011

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity